SCHEMBL6406142

SCHEMBL6406142

CCc1ccc(OCc2nnc(SCC#N)n2CC)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.67
CYP3A4 P08684 1/20 0.67
CYP2C9 P11712 1/20 0.67
CYP2C19 P33261 1/20 0.67
SMN1; SMN2 Q16637 6/20 0.66
HTT P42858 3/20 0.66
POLB P06746 3/20 0.66
ADRB2 P07550 1/20 0.66
TSHR P16473 2/20 0.65
MEN1 O00255 4/20 0.64
KMT2A Q03164 4/20 0.64
CPB1 P15086 1/20 0.54
ALDH1A1 P00352 6/20 0.54
KDM4E B2RXH2 2/20 0.54
NPSR1 Q6W5P4 6/20 0.53
LMNA P02545 5/20 0.51
GAA P10253 4/20 0.50
L3MBTL1 Q9Y468 1/20 0.48
MAPT P10636 1/20 0.45
HSD17B10 Q99714 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21237142 0.80 HTT (1.00) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL6410268 0.79 CYP1A2 (0.87) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL6403245 0.75 TSHR (0.82) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL6412252 0.74 PKM (0.56) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL4206437 0.73 SMN1; SMN2 (0.78) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL6404140 0.73 TSHR (0.71) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL6407491 0.72 PKM (0.60) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL6408782 0.70 LMNA (0.51) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL6264446 0.70 TSHR (0.64) CYP1A2CYP3A4CYP2C9CYP2C19SMN1; SMN2
SCHEMBL6404334 0.70 GAA (0.71) CYP1A2SMN1; SMN2HTTPOLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT CYP1A2 93/4885CYP3A4 25/4885CYP2C9 128/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.